Ultramarine Bio: The nitrapyrin ointment jointly applied for by the company and its subsidiaries has obtained a new veterinary drug registration certificate.

Weilan Biology announced that the "Midanping cream" jointly applied by the company and its wholly-owned subsidiaries, Qingdao Weilan To Pet Biotechnology Co., Ltd., and Qingdao Kangdien Animal Pharmaceutical Co., Ltd., along with other units, has been approved as a class V new veterinary medicine and has recently been issued a "New Veterinary Medicine Registration Certificate". The product is mainly used to control weight loss in cats and was jointly developed by the company and its wholly-owned subsidiaries along with multiple units, with a total research and development cost of 1.8622 million yuan. The acquisition of the new veterinary medicine certificate is expected to bring new performance growth points to the company's business.